1. >
  2. search-en

Search

Found 399 Results
Page 1 of 40

Onxeo Announces its Financial Agenda for 2022


Paris (France), January 13, 2022 – 6 pm CET – Onxeo S.A. (Euronext Growth Paris: ALONX, First North Copenhagen: ONXEO), […]

01/13/2022


Onxeo appoints Julien Miara as new interim CEO


Paris (France), January 3rd, 2022 – 6:00 pm CET – Onxeo S.A. (Euronext Growth Paris: ALONX, First North Copenhagen: ONXEO), (“Onxeo” or “the Company”), […]

01/03/2022


New preclinical data confirm the ability of AsiDNA™ to tackle the drug-tolerant persister cells and prevent tumor resistance in several combination treatments


These pioneering data were highlighted at the EACR-AstraZeneca Virtual Conference during two dedicated sessions   Paris (France), December 8, 2021 […]

12/08/2021


Onxeo Continues to Strengthen its Board of Directors


Bryan Giraudo, COO & CFO of U.S. biopharmaceutical company Gossamer Bio, joins the Company’s Board as independent member   Paris […]

11/23/2021


Onxeo Further strengthens its Board of Directors with two Seasoned Personalities from the Healthcare Sector


Dr Robert L. Coleman, Chief Scientific Officer of US Oncology Network and Dr Jacques Mallet, former SVP Portfolio Analytics/Corporate Strategy […]

10/14/2021


Sponsor/ Advisor


  Listing Sponsor – Euronext Growth Paris   Certified Advisor – Nasdaq First North Copenhagen Invest Corporate Finance 73 bd. […]

08/12/2021


Onxeo Reports its 2021 Half-Yearly Financial Results and Provides an Update on its Activities


Cash position of €24.5 million as of June 30, 2021, providing financial visibility until the end of 2022 and enabling […]

07/29/2021


Onxeo Announces the Appointment of Dr. Shefali Agarwal as the Company’s Chairwoman of the Board


Danièle Guyot-Caparros, outgoing Chairwoman, remains an independent member of the Board of Directors and Chair of the Audit Committee   […]

Tags:


Annual General Meeting 2021-video


COMBINED GENERAL MEETING OF JUNE 10, 2021 IN CAMERA INVESTORS

06/11/2021


Onxeo: Report on the Combined General Meeting of June 10, 2021


All resolutions voted in accordance with Board of Directors’ recommendations Shefali Agarwal, MD, a clinical development expert in oncology, is […]

06/10/2021


Page 1 of 40

No more results